Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya

Lancet

Volumn 355, Issue 9211, 2000, Pages 1225-1230

  Scott, J A G ^a,b,c   Hall, A J ^a   Muyodi, C ^c   Lowe, B ^b   Ross, M ^d   Chohan, B ^c   Mandaliya, K ^c   Getambu, E ^c   Gleeson, F ^e   Drobniewski, F ^f   Marsh, K ^b,g  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c Department of Obstetrics and Gynaecology   (Kenya)

^d ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

^e CHURCHILL HOSPITAL   (United Kingdom)

^f PUBLIC HEALTH ENGLAND   (United Kingdom)

^g UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BACTERIAL ANTIGEN; CEFUROXIME; CLOXACILLIN; PENICILLIN G; PENICILLIN V;

ADOLESCENT; ADULT; AGE; ARTICLE; BLOOD CULTURE; CONVALESCENCE; FEMALE; HEART RATE; HERPES LABIALIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION RISK; KENYA; LUNG ASPIRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHARMACY; PNEUMONIA; PRIORITY JOURNAL; PUBLIC HOSPITAL; RADIODIAGNOSIS; RURAL AREA; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; TRADITIONAL MEDICINE; UNEMPLOYMENT; URBAN AREA;

EID: 17144449325     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02089-4     Document Type: Article

References (30)

1. Williams E.H., Hayes R.J., Smith P.G. Admissions to a rural hospital in the West Nile District of Uganda over a 27 year period. J Trop Med Hyg. 89:1986;193-211.
2. Harries A.D., Speare R., Wirima J.J. Medical admissions to Kamuzu Central Hospital, Lilongwe, Malawi in 1986: comparison with admissions to Queen Elizabeth Central Hospital, Blantyre in 1973. Trop Geogr Med. 42:1990;274-279.
3. Macfarlane J.T., Adegboye D.S., Warrell M.J. Mycoplasma pneumoniae and aetiology of lobar pneumonia in northern Nigeria. Thorax. 34:1979;713-719.
4. Allen S.C. Lobar pneumonia in Northern Zambia. clinical study of 502 patients Thorax. 39:1984;612-616.
5. Scott J.A.G., Hall A.J. The value and complications of percutaneous transthoracic lung aspiration for the etiological diagnosis of community acquired pneumonia. Chest. 116:1999;1716-1732.
6. Scott J.A.G., Hall A.J., Hannington A.et al. Serotype distribution and prevalence of resistance to benzylpenicillin in three representative populations of Streptococcus pneumoniae isolates from the coast of Kenya. Clin Infect Dis. 27:1998;1442-1450.
7. Drobniewski R.A., Uttley A.H.C. Mycobacterial speciation. Parrish T., Stoker N. Mycobacteria protocols. 1998;323-348 Humana Press, Totowa.
8. Scott J.A.G., Hannington A., Marsh K., Hall A.J. Diagnosis of pneumococcal pneumonia in epidemiological studies. evaluation of Kenyan adults of a serotype-specific urine latex agglutination assay Clin Infect Dis. 28:1999;764-769.
9. Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. Q J M. 62:1987;195-220.
10. Fang G.D., Fine M., Orloff J.et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multicenter study of 359 cases. Medicine (Baltimore). 69:1990;307-316.
11. Macfarlane J.T., Finch R.G., Ward M.J., Macrae A.D. Hospital study of adult community-acquired pneumonia. Lancet. ii:1982;255-258.
12. Marston B.J., Plouffe J.F., File T.M. Jr.et al. Incidence of community-acquired pneumonia requiring hospitalization: results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med. 157:1997;1709-1718.
13. Davidson M., Tempest B., Palmer D. Bacteriologic diagnosis of acute pneumonia. comparison of sputum, transtracheal aspirates and lung aspirates JAMA. 235:1976;158-163.
14. Shann F., Gratten M., Germer S., Linnemann V., Hazlett D., Payne R. Aetiology of pneumonia in children in Goroka hospital, Papua New Guinea. Lancet. ii:1984;537-541.
15. Hirschtick R.E., Glassroth J., Jordan M.C.et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Engl J Med. 333:1995;845-851.
16. Wallace R.J. Jr., Musher D.M., Martin R.R. Haemophilus influenzae pneumonia in adults. Am J Med. 64:1978;87-93.
17. Aderaye G. Community acquired pneumonia in adults in Addis Abeba. etiologic agents, clinical and radiographic presentation Ethiop Med J. 32:1994;115-123.
18. Lind K., Bentzon M.W. Changes in the epidemiological pattern of Mycoplasma pneumoniae infections in Denmark. a 30 year survey Epidemiol Infect. 101:1988;377-386.
19. Batungwanayo J., Taelman H., Lucas S.et al. Pulmonary disease associated with human immunodeficiency virus in Kigali, Rwanda. Am J Respir Crit Care Med. 149:1994;1591-1596.
20. Abouya Y.L., Beaumel A., Lucas S.et al. Pneumocystis carinii pneumonia. an uncommon cause of death in African patients with acquired immunodeficiency syndrome Am Rev Respir Dis. 145:1992;617-620.
21. Kamanfu G., Mlika-Cabanne N., Girard P.M.et al. Pulmonary complications of human immunodeficiency virus infection in Bujumbura, Burundi. Am Rev Respir Dis. 147:1993;658-663.
22. Daley C.L., Mugusi F., Chen L.L.et al. Pulmonary complications of HIV infection in Dar es Salaam, Tanzania. role of bronchoscopy and bronchoalveolar lavage Am J Respir Crit Care Med. 154:1996;105-110.
23. Koulla-Shiro S., Kuaban C., Belec L. Acute community-acquired bacterial pneumonia in human immunodeficiency virus (HIV) infected and non-HIV-infected adult patients in Cameroon. aetiology and outcome Tuber Lung Dis. 77:1996;47-51.
24. Sofowora E.O., Onadeko B.O. Complications and prognostic factors in pneumonia among Nigerians. Niger Med J. 3:1973;144-145.
25. Sow O., Frechet M., Diallo A.A.et al. Community acquired pneumonia in adults. a study comparing clinical features and outcome in Africa (Republic of Guinea) and Europe (France) Thorax. 51:1996;385-388.
26. Fine M.J., Orloff J.J., Arisumi D.et al. Prognosis of patients hospitalized with community-acquired pneumonia. Am J Med. 88:1990;1N-8N.
27. Mundy L.M., Auwaerter P.G., Oldach D.et al. Community-acquired pneumonia. impact of immune status Am J Respir Crit Care Med. 152:1995;1309-1315.
28. Klugman K.P. The clinical relevance of in-vitro resistance to penicillin, ampicillin, amoxycillin and alternative agents, for the treatment of community acquired pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. J Antimicrob Chemother. 38:1996;S133-140. (suppl A).
29. Pallares R., Linares J., Vadillo M.et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med. 333:1995;474-480.
30. Austrian R., Gold J. Pneumococcal bacteraemia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med. 60:1964;759-776.